0000899243-22-001923.txt : 20220113 0000899243-22-001923.hdr.sgml : 20220113 20220113172029 ACCESSION NUMBER: 0000899243-22-001923 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220111 FILED AS OF DATE: 20220113 DATE AS OF CHANGE: 20220113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CURTIS NICHOLAS T CENTRAL INDEX KEY: 0001230265 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39473 FILM NUMBER: 22529808 MAIL ADDRESS: STREET 1: C/O STAAR SURGICAL CO STREET 2: 1911 WALKER AVE CITY: MONROVIA STATE: CA ZIP: 91016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LENSAR, Inc. CENTRAL INDEX KEY: 0001320350 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 320125724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2800 DISCOVERY DRIVE STREET 2: SUITE 100 CITY: ORLANDO STATE: FL ZIP: 32826 BUSINESS PHONE: 888-536-7271 MAIL ADDRESS: STREET 1: 2800 DISCOVERY DRIVE STREET 2: SUITE 100 CITY: ORLANDO STATE: FL ZIP: 32826 FORMER COMPANY: FORMER CONFORMED NAME: LensAR Inc DATE OF NAME CHANGE: 20070703 FORMER COMPANY: FORMER CONFORMED NAME: LaserSoft Vision Inc DATE OF NAME CHANGE: 20050310 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-11 0 0001320350 LENSAR, Inc. LNSR 0001230265 CURTIS NICHOLAS T C/O LENSAR, INC. 2800 DISCOVERY DRIVE ORLANDO FL 32826 1 1 0 0 Chief Executive Officer Common Stock 2022-01-11 4 A 0 30000 0.00 A 770850 D Stock Option (Right to Buy) 6.04 2022-01-11 4 A 0 105000 0.00 A 2032-01-11 Common Stock 105000 105000 D Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in four (4) substantially equal annual installments on each anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. The option vests as to 25% of the award on January 11, 2023 and, as to the remaining amount of the award, in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. /s/ Thomas R. Staab, II, attorney-in-fact 2022-01-13